CAMPHOR (SYNTHETIC), LEVOMENTHOL, AND CAPSICUM

CAMPHOR (SYNTHETIC), LEVOMENTHOL, AND CAPSICUM was reported 82 times

CAMPHOR (SYNTHETIC), LEVOMENTHOL, AND CAPSICUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMICAL BURN OF RESPIRATORY TRACT 1 0.0128
1 SERUM AMYLOID A PROTEIN INCREASED 1 0.0065
2 EPIDURAL INJECTION 1 0.0051
3 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
4 EXPOSURE VIA INHALATION 1 0.0046
5 CATHETER SITE RELATED REACTION 1 0.0013
6 PERIORBITAL PAIN 1 0.0012
7 MEDICATION OVERUSE HEADACHE 1 0.0012
8 BURNS SECOND DEGREE 2 0.0011
9 BURNS THIRD DEGREE 1 0.0009
10 CARDIAC HYPERTROPHY 1 0.0009
11 CATHETER SITE DISCHARGE 1 0.0009
12 OVARIAN CYST RUPTURED 1 0.0008
13 TONGUE DRY 1 0.0007
14 HALLUCINATIONS, MIXED 3 0.0007
15 CONNECTIVE TISSUE DISORDER 1 0.0007
16 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
17 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
18 NIPPLE PAIN 1 0.0005
19 CHEMICAL BURN OF SKIN 1 0.0004
20 MENOPAUSE 1 0.0004
21 ANORGASMIA 1 0.0004
22 JOINT LOCK 1 0.0004
23 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
24 SINUS HEADACHE 2 0.0003
25 ATYPICAL PNEUMONIA 1 0.0003
26 PLANTAR FASCIITIS 1 0.0003
27 BOWEL MOVEMENT IRREGULARITY 2 0.0003
28 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
29 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
30 OESOPHAGEAL CANDIDIASIS 1 0.0003
31 ENURESIS 1 0.0002
32 SLEEP TERROR 1 0.0002
33 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
34 HEPATIC PAIN 1 0.0002
35 LIGAMENT RUPTURE 1 0.0002
36 HAEMOGLOBIN INCREASED 1 0.0002
37 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
38 SKIN TIGHTNESS 1 0.0002
39 VULVOVAGINAL PAIN 1 0.0002
40 INCREASED UPPER AIRWAY SECRETION 1 0.0002
41 SENSITIVITY TO WEATHER CHANGE 1 0.0002
42 PHARYNGOLARYNGEAL PAIN 1 0.0002
43 PRE-EXISTING CONDITION IMPROVED 1 0.0002
44 PROCTALGIA 1 0.0002
45 HERPES SIMPLEX 1 0.0002
46 TENDON DISORDER 1 0.0002
47 SKIN MASS 1 0.0001
48 MENINGITIS 1 0.0001
49 APPLICATION SITE RASH 2 0.0001
50 ONYCHOCLASIS 1 0.0001
51 APPLICATION SITE REACTION 1 0.0001
52 SEASONAL ALLERGY 2 0.0001
53 CEREBRAL DISORDER 1 0.0001
54 APPLICATION SITE PRURITUS 3 0.0001
55 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
56 CONCUSSION 1 0.0001
57 MULTIPLE ALLERGIES 1 0.0001
58 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
59 FRUSTRATION TOLERANCE DECREASED 1 0.0001
60 ESCHERICHIA INFECTION 1 0.0001
61 INADEQUATE ANALGESIA 1 0.0001
62 BLOOD CALCIUM INCREASED 1 0.0001
63 INCREASED TENDENCY TO BRUISE 1 0.0001
64 OVARIAN CANCER 1 0.0001
65 FLANK PAIN 1 0.0001
66 SPUTUM DISCOLOURED 1 0.0001
67 THERAPY CHANGE 1 0.0001
68 DISORIENTATION 4 0.0001
69 OVARIAN CYST 1 0.0001
70 EUPHORIC MOOD 1 0.0001
71 PRODUCT ODOUR ABNORMAL 1 0.0001
72 BODY HEIGHT DECREASED 1 0.0001
73 IRRITABLE BOWEL SYNDROME 2 0.0001
74 DECREASED ACTIVITY 1 0.0001
75 ORAL PAIN 2 0.0001
76 MICTURITION URGENCY 1 0.0001
77 SPLENOMEGALY 1 0.0001
78 SPINAL PAIN 1 0.0001
79 BURSITIS 1 0.0001
80 INCORRECT PRODUCT STORAGE 1 0.0001
81 PRODUCT TASTE ABNORMAL 1 0.0001
82 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
83 BLINDNESS UNILATERAL 1 0.0001
84 PAIN IN JAW 2 0.0001
85 MUSCULOSKELETAL CHEST PAIN 1 0.0001
86 TENDONITIS 1 0.0001
87 MUSCLE TIGHTNESS 1 0.0001
88 BLOOD POTASSIUM INCREASED 1 0.0001
89 URINARY RETENTION 2 0.0001
90 MUSCULOSKELETAL DISCOMFORT 1 0.0001
91 THIRST 1 0.0001
92 TOOTHACHE 1 0.0001
93 BLISTER 3 0.0001
94 DYSPNOEA EXERTIONAL 2 0.0001
95 CHOLESTASIS 1 0.0001
96 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
97 SINUS DISORDER 1 0.0001
98 FULL BLOOD COUNT DECREASED 1 0.0000
99 PRODUCT PHYSICAL ISSUE 1 0.0000
100 RIB FRACTURE 1 0.0000
101 PULMONARY HYPERTENSION 1 0.0000
102 FAECES DISCOLOURED 1 0.0000
103 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
104 APPLICATION SITE PAIN 1 0.0000
105 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
106 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
107 SKIN IRRITATION 2 0.0000
108 MENTAL IMPAIRMENT 1 0.0000
109 NEURALGIA 1 0.0000
110 AGEUSIA 1 0.0000
111 ANAPHYLACTIC SHOCK 1 0.0000
112 APPLICATION SITE ERYTHEMA 1 0.0000
113 FREQUENT BOWEL MOVEMENTS 1 0.0000
114 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
115 BACK PAIN 8 0.0000
116 PSYCHOTIC DISORDER 1 0.0000
117 IRRITABILITY 2 0.0000
118 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
119 DISCOMFORT 2 0.0000
120 NEUROPATHY PERIPHERAL 3 0.0000
121 CYSTITIS 1 0.0000
122 CHOLELITHIASIS 1 0.0000
123 TREMOR 5 0.0000
124 ANGER 1 0.0000
125 HAEMATURIA 1 0.0000
126 GASTRIC DISORDER 1 0.0000
127 RASH MACULAR 1 0.0000
128 BURNING SENSATION 2 0.0000
129 MOBILITY DECREASED 2 0.0000
130 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
131 CRYING 1 0.0000
132 C-REACTIVE PROTEIN INCREASED 1 0.0000
133 BRONCHITIS 2 0.0000
134 RHEUMATOID ARTHRITIS 3 0.0000
135 PERIPHERAL SWELLING 4 0.0000
136 POLLAKIURIA 1 0.0000
137 ROAD TRAFFIC ACCIDENT 1 0.0000
138 URTICARIA 4 0.0000
139 OSTEOARTHRITIS 1 0.0000
140 HYPOACUSIS 1 0.0000
141 PSORIASIS 3 0.0000
142 MUSCULOSKELETAL STIFFNESS 2 0.0000
143 RENAL FAILURE 3 0.0000
144 THERAPY NON-RESPONDER 1 0.0000
145 NEPHROLITHIASIS 1 0.0000
146 SKIN DISCOLOURATION 1 0.0000
147 COGNITIVE DISORDER 1 0.0000
148 DYSPHAGIA 2 0.0000
149 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
150 CONTUSION 2 0.0000
151 LUNG DISORDER 1 0.0000
152 CHEST DISCOMFORT 2 0.0000
153 SINUSITIS 2 0.0000
154 THERAPY CESSATION 1 0.0000
155 SPEECH DISORDER 1 0.0000
156 DRUG EFFECT DECREASED 1 0.0000
157 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
158 ARTHROPATHY 1 0.0000
159 NECK PAIN 1 0.0000
160 PANCYTOPENIA 1 0.0000
161 OXYGEN SATURATION DECREASED 1 0.0000
162 FLATULENCE 1 0.0000
163 SEIZURE 2 0.0000
164 NASAL CONGESTION 1 0.0000
165 DISEASE PROGRESSION 2 0.0000
166 STOMATITIS 1 0.0000
167 VISUAL IMPAIRMENT 2 0.0000
168 HYPERHIDROSIS 2 0.0000
169 AMNESIA 1 0.0000
170 PRODUCT DOSE OMISSION 1 0.0000
171 ERYTHEMA 3 0.0000
172 MEMORY IMPAIRMENT 2 0.0000
173 INJURY 1 0.0000
174 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
175 PAIN IN EXTREMITY 4 0.0000
176 WEIGHT INCREASED 3 0.0000
177 UNEVALUABLE EVENT 1 0.0000
178 PAIN 8 0.0000
179 PRURITUS 5 0.0000
180 ARTHRITIS 1 0.0000
181 CARDIAC FAILURE CONGESTIVE 1 0.0000
182 DRY MOUTH 1 0.0000
183 GASTROINTESTINAL DISORDER 1 0.0000
184 ASTHENIA 4 0.0000
185 MIGRAINE 1 0.0000
186 ATRIAL FIBRILLATION 1 0.0000
187 PRODUCT DOSE OMISSION ISSUE 3 0.0000
188 DYSPEPSIA 1 0.0000
189 NAUSEA 8 0.0000
190 SYNCOPE 1 0.0000
191 HYPOTENSION 2 0.0000
192 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
193 FLUSHING 1 0.0000
194 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
195 ARTHRALGIA 4 0.0000
196 FALL 3 0.0000
197 ASTHMA 1 0.0000
198 DYSPNOEA 5 0.0000
199 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
200 ABDOMINAL PAIN 2 0.0000
201 CHILLS 1 0.0000
202 VOMITING 4 0.0000
203 JOINT SWELLING 1 0.0000
204 OEDEMA PERIPHERAL 1 0.0000
205 DRUG INEFFECTIVE 10 0.0000
206 WEIGHT DECREASED 2 0.0000
207 COUGH 2 0.0000
208 HYPOAESTHESIA 1 0.0000
209 BLOOD PRESSURE INCREASED 1 0.0000
210 FATIGUE 5 0.0000
211 PNEUMONIA 2 0.0000
212 DRUG DOSE OMISSION 1 0.0000
213 DIZZINESS 3 0.0000
214 ABDOMINAL DISCOMFORT 1 0.0000
215 MYALGIA 1 0.0000
216 URINARY TRACT INFECTION 1 0.0000
217 PYREXIA 2 0.0000
218 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
219 MUSCLE SPASMS 1 0.0000
220 NASOPHARYNGITIS 1 0.0000
221 CHEST PAIN 1 0.0000
222 HYPERSENSITIVITY 1 0.0000
223 PRODUCT USE ISSUE 1 0.0000
224 GAIT DISTURBANCE 1 0.0000
225 ABDOMINAL PAIN UPPER 1 0.0000
226 HEADACHE 3 0.0000
227 DIARRHOEA 3 0.0000
228 RASH 2 0.0000
229 CONSTIPATION 1 0.0000
230 DEPRESSION 1 0.0000
231 INCORRECT DOSE ADMINISTERED 1 0.0000
232 DECREASED APPETITE 1 0.0000
233 FEELING ABNORMAL 1 0.0000
234 INSOMNIA 1 0.0000
235 ANXIETY 1 0.0000
236 CONDITION AGGRAVATED 1 0.0000
237 INJECTION SITE PAIN 1 0.0000
238 MALAISE 1 0.0000